RecruitingNCT04923178

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies


Sponsor

National Cancer Institute (NCI)

Enrollment

1,100 participants

Start Date

Oct 24, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Tumors in the genitourinary tracts can occur in the kidney, bladder, prostate, and testicles and can have common and rare histologies. Some cancers that occur along the genitourinary (GU) tract are rare. Some GU tumors are so rare that they are not included in treatment studies or tissue banks. This makes it hard for researchers to determine standards of care. Researchers want to learn more about common and rare GU tumors. Objective: To learn more about urinary tract cancers. Eligibility: People ages 18 and older with urinary tract or GU cancer such as bladder, kidney, testicular, prostate, penis, or neuroendocrine cancer. Design: Participants will be screened with questions about their medical history. Their medical records will be reviewed. Participants will have a physical exam. They will give blood and urine samples. They will complete a survey about their family cancer history. Clinical photographs will be taken to document skin lesions. Participants may have imaging scans of their chest, abdomen, and pelvis. They may have a contrast agent injected into their arm. Participants will get recommendations about how to best manage and treat their cancer. They can ask as many questions as they would like. Participants will provide existing tumor samples if available. They may have optional tumor biopsies up to twice a year. For needle biopsies, the biopsy area will be numbed and they will get a sedative. A needle will be inserted through their skin to collect a tumor sample. For skin biopsies, their skin will be numbed. A small circle of skin will be removed. Some blood and tumor samples may be used for genetic tests. Participants will have frequent follow-up visits. If they cannot visit NIH, their home doctor will be contacted. They will be followed on this study for life....


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a registry (a large database) of people with rare urinary tract and genital cancers, including unusual types of bladder, kidney, prostate, penile, and testicular cancers, to better understand how these diseases behave over time. **You may be eligible if:** - You are 18 or older - You have a confirmed diagnosis of urothelial cancer or a rare genitourinary cancer (such as small cell bladder cancer, penile cancer, testicular cancer, renal medullary carcinoma, and many other rare variants) - You are willing and able to give written consent **You may NOT be eligible if:** - There are no specific exclusion criteria listed for this study — most people with a confirmed qualifying diagnosis may be eligible Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04923178


Related Trials